Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BN.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-463.749South Korea
BN.1.3.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-463.749South Korea
BF.25EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.9EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.7.4.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-463.749South Korea
BN.1.3.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-463.749South Korea
BL.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-463.749South Korea
BA.5.2.47EWon-ECACACAATCGATGCGCAGTA20502636526346R-463.749South Korea
ED.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-463.749South Korea
BF.38.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BT.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.55EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.76EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.1.30EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BE.11EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.9EWon-ECACACAATCGATGCGCAGTA20502636526346R-463.749South Korea
BF.31EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.4.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.24EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.3.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.3.13EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.3.9EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.10.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.56EWon-ECACACAATCGATGCGCAGTA20502636526346R-463.749South Korea
BA.2.29EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.10EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.51EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.3.18EWon-ECACACAATCGATGCGCAGTA20502636526346R-463.749South Korea
XATEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.24EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.12EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BM.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-463.749South Korea
BA.5.2.28EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.62EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.24EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-463.749South Korea
BA.2.13.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.28EWon-ECACACAATCGATGCGCAGTA20502636526346R-463.749South Korea
BA.5.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BE.1.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XAZEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BE.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.1.24EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.1.16EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.26EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.22EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.21EWon-ECACACAATCGATGCGCAGTA20502636526346R-463.749South Korea
BA.5.2.22EWon-ECACACAATCGATGCGCAGTA20502636526346R-463.749South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used